萊美藥業(300006.SZ):擬由艾丁格爾對湖南康源實施整體承包經營
格隆匯 2 月 8日丨萊美藥業(300006.SZ)公佈,公司於2021年2月5日召開的第五屆董事會第十二次會議和第五屆監事會第九次會議分別審議通過了《關於簽署<承包經營協議>的議案》,同意公司、全資子公司湖南康源製藥有限公司(“湖南康源”、“目標公司”)與湖南艾丁格爾科技有限公司(“艾丁格爾”)共同簽署《承包經營協議》,由艾丁格爾對湖南康源實施整體承包經營,首次承包經營期限3年。承包期間,無論湖南康源盈虧,湖南康源每年從艾丁格爾淨收取人民幣1200萬元的承包費。
湖南康源系公司全資子公司,主要從事生產、銷售大容量注射劑等。目前大輸液行業市場競爭較為激烈,本次承包方艾丁格爾管理團隊在大輸液領域擁有豐富的行業經驗和市場渠道,公司全資子公司湖南康源委託艾丁格爾進行經營管理,將有利於湖南康源提升運營效率,拓寬市場銷售渠道,同時有利於公司優化資產配置,減少相關資產帶來的影響,進一步聚焦抗腫瘤、消化道、抗感染等優勢細分領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.